Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer.

Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer.
复制标题

DOI:
10.1016/j.ccell.2018.10.003
复制
发表时间:
2018-11-12
期刊:
影响因子:
50.3
通讯作者:
Taylor BS
Taylor BS
中科院分区:
医学1区
文献类型:
--
作者:
Bielski CM;Donoghue MTA;Gadiya M;Hanrahan AJ;Won HH;Chang MT;Jonsson P;Penson AV;Gorelick A;Harris C;Schram AM;Syed A;Zehir A;Chapman PB;Hyman DM;Solit DB;Shannon K;Chandarlapaty S;Berger MF;Taylor BS

文献摘要

参考文献

被引文献

相似文献

癌基因中的驱动突变编码具有增强适应性的功能获得特性的蛋白质。因此,杂合突变被视为足以发生肿瘤。我们描述了13,448例前瞻性特征性癌症中广泛存在的致癌突变等位基因失衡。通过适度增加适应性获得突变的剂量来选择不平衡。负选择靶向剪接体的单倍必需效应子。正常等位基因的丢失包括由竞争适应度驱动的一类独特的不平衡,这与对靶向治疗的反应增强相关。在许多癌症中,一个先行的致癌突变驱动了进化依赖的等位基因特异性失衡。在其他情况下,致癌突变通过外适应的进化过程选择独立的拷贝数变化。致癌等位基因失衡是一种普遍的进化创新,可增强适应性并调节对靶向治疗的敏感性。
Driver mutations in oncogenes encode proteins with gain-of-function properties that enhance fitness. Heterozygous mutations are thus viewed as sufficient for tumorigenesis. We describe widespread oncogenic mutant allele imbalance in 13,448 prospectively characterized cancers. Imbalance was selected for through modest dosage increases of gain-of-fitness mutations. Negative selection targeted haplo-essential effectors of the spliceosome. Loss of the normal allele comprised a distinct class of imbalance driven by competitive fitness, which correlated with enhanced response to targeted therapies. In many cancers, an antecedent oncogenic mutation drove evolutionarily dependent allele-specific imbalance. In other instances, oncogenic mutations co-opted independent copy number changes via the evolutionary process of exaptation. Oncogenic allele imbalance is a pervasive evolutionary innovation that enhances fitness and modulates sensitivity to targeted therapy.
DOI: 10.1126/scisignal.2004088
发表时间: 2013-04-02
期刊: Science signaling
影响因子: 7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者: Schultz N
DOI: 10.1017/s0094837300004310
发表时间: 1982-01-01
期刊: PALEOBIOLOGY
影响因子: 2.7
作者:
GOULD, SJ;VRBA, ES
通讯作者: VRBA, ES
DOI: 10.1016/j.cell.2017.01.020
发表时间: 2017-02-23
期刊: Cell
影响因子: 64.5
作者:
Burgess MR;Hwang E;Mroue R;Bielski CM;Wandler AM;Huang BJ;Firestone AJ;Young A;Lacap JA;Crocker L;Asthana S;Davis EM;Xu J;Akagi K;Le Beau MM;Li Q;Haley B;Stokoe D;Sampath D;Taylor BS;Evangelista M;Shannon K
通讯作者: Shannon K
DOI: 10.1126/scitranslmed.aaa1408
发表时间: 2015-04-15
影响因子: 17.1
作者:
McGranahan N;Favero F;de Bruin EC;Birkbak NJ;Szallasi Z;Swanton C
通讯作者: Swanton C
DOI: 10.1186/s12885-015-1515-3
发表时间: 2015-07-04
期刊: BMC cancer
影响因子: 3.8
作者:
Hélias-Rodzewicz Z;Funck-Brentano E;Baudoux L;Jung CK;Zimmermann U;Marin C;Clerici T;Le Gall C;Peschaud F;Taly V;Saiag P;Emile JF
通讯作者: Emile JF